a patient-focused, innovative, commercial-stage, global biopharmaceutical company, will present new data from its internal oncology discovery portfolio at the upcoming 2022American Association for Cancer Research(AACR) Annual Meeting inNew OrleansonApril 8-13, 2022....
The World Health Organization predicts we will see more than 35 million new cancer cases by 2050, a 77% increase from the estimated 20 million cases in 2022. The data comes from a report the organization's cancer agency, the International Agency for Research on Cancer, released ahead...
56:32 RSNA2022:来自Radiology编辑-应该会影响临床实践的研究(From the Editors of RADIOLOGY New Research) 56:35 RSNA2022:消化系统与泌尿生殖系统病例对抗赛(Jeopardy GIGU Cases) 1:24:31 RSNA2022:肌骨系统肿瘤影像学精粹与误区(MSK Tumors Pearls and Pitfalls) 1:03:18 RSNA2022:住院医师急诊夜班-勿漏...
March 29, 2022Diet ByJames Brown,Aston University Sweeteners have long been suggested to be bad for our health. Studies have linked consuming too many sweeteners with conditions such asobesity,type 2 diabetes and cardiovascular disease. But links with cancer have been less certain. ...
Don’t miss the newest articles. Keep up to date with the latest research, clinical reviews, and opinions.
Addressing challenges in radiomics research: systematic review and repository of open-access cancer imaging datasets. Insights into Imaging. 2023;14(1):216. Article PubMed PubMed Central Google Scholar Zanfardino M, Pane K, Mirabelli P, Salvatore M, Franzese M. TCGA-TCIA impact on Radio...
SEOUL, South Korea, May 26, 2022 /PRNewswire/ -- New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment
There have been major advances in the immunotherapy of cancer in recent years, including the development of T cell engagers — antibodies engineered to redirect T cells to recognize and kill cancer cells — for the treatment of haematological malignancies. However, the field still faces several chal...
research, including immunotherapies, as well as patient outreach tools. At the Cancer Research Institute,$400M has been investedin immunotherapy research, while the National Cancer Institute continues to support immunotherapy byfunding the continuumfrom basic scientific research to clinical research ...
Research Open access Published: 27 January 2024 Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy Sonia Alcalá, Lara Villarino, Laura Ruiz-Cañas, José R. Couceiro, Miguel Martínez-Calvo, Adrián Palencia-Campos, Diego Navarro, Pablo ...